Results 111 to 120 of about 139,227 (225)

Incidence of Childhood Dilated Cardiomyopathy in Sweden From 1991 to 2019: A National Population‐Based Study

open access: yesActa Paediatrica, Volume 115, Issue 12, Page 2743-2751, December 2026.
ABSTRACT Aim To study the incidence, survival, and mortality of dilated cardiomyopathy (DCM) in children in Sweden, 1991–2019. Methods Hospital records of 0–18‐year‐olds diagnosed with DCM over a 29‐year period were reviewed. The annual sex‐specific incidence rates of DCM were calculated as new disease cases, divided by the average Swedish same‐sex ...
Shalan Fadl   +5 more
wiley   +1 more source

Electrocardiographic criteria in founder mutations related to Arrhythmogenic cardiomyopathy

open access: yes, 2018
Founder mutations are rare causes in arrhythmogenic cardiomyopathy including TMEM43 und phospholamban mutations. The incidence is approximately 1%. P.S358L TMEM43 mutations cause aggressive, in most cases biventricular arrhythmogenic cardiomyopathy [1 ...
Peters Stefan, Stefan Peters*
core   +1 more source

Arrhythmogenic Cardiomyopathy: Focus on Imaging

open access: yesJournal of the Indian Academy of Echocardiography & Cardiovascular Imaging
Arrhythmogenic cardiomyopathy (AC) is a broad term denoting subclinical or clinical heart muscle disease which presents predominantly with serious arrhythmias.
Madhu Shukla   +3 more
doaj   +1 more source

Acute Angina in Anomalous Left Main Coronary Artery With Prepulmonic Course: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Although a prepulmonic left main coronary artery is usually considered a lower‐risk AAOCA subtype, it may still be associated with acute ischemic symptoms when significant atherosclerotic coronary artery disease is present. Multimodality imaging is essential for defining the coronary anatomy, and coronary artery bypass grafting may be the ...
Mohammad Rouzbahani   +4 more
wiley   +1 more source

The Many Faces of Arrhythmogenic Cardiomyopathy: An Overview

open access: yesThe Application of Clinical Genetics, 2023
Hanna J Tadros,1 Christina Y Miyake,1,2 Debra L Kearney,3 Jeffrey J Kim,1 Susan W Denfield4 1Department of Pediatrics, Section of Pediatric Cardiology, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX, USA; 2Department of Molecular ...
Tadros HJ   +4 more
doaj  

Late INa as a Therapeutic Target: New Strategies, Computational Modelling, Drug Development, and Clinical Translation

open access: yesMedicinal Research Reviews, Volume 46, Issue 6, Page 1939-1957, November 2026.
ABSTRACT The Nav1.5 channel, a major isoform of voltage‐gated sodium ion channel, is mainly found in ventricular cardiomyocytes, playing a key role in generating essential cardiac action potentials for normal heart rhythms. Mutations in Nav1.5 have been associated with severe heart conditions such as long QT syndrome, Brugada syndrome, cardiac ...
Arkapravo Chattopadhyay   +3 more
wiley   +1 more source

Distribution of biventricular disease in arrhythmogenic cardiomyopathy: an autopsy study

open access: yes, 2012
Arrhythmogenic cardiomyopathy is a rare cardiomyopathy characterized by fibrofatty replacement primarily of the right ventricular myocardium. It is a major cause of sudden death in the young and in athletes.
Li, Ling   +17 more
core   +1 more source

A late-onset arrhythmogenic right ventricular cardiomyopathy unveiled by supraventricular tachycardia: Case report

open access: yesRadiology Case Reports
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare myocardial genetic disease that leads to heart failure and sudden cardiac death. The diagnosis of ARVC remains challenging given its variable presentation.
Manal Msirdi   +4 more
doaj   +1 more source

Integrative Approaches in Cardiovascular Disease: The Role of Nutraceuticals in Heart Failure, Atrial Fibrillation, and Related Conditions

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6249-6275, November 2026.
Schematic representation of the shared pathophysiological mechanisms underlying heart failure (HF) and atrial fibrillation (AF), including inflammation, oxidative stress, endothelial dysfunction, and fibrosis. The figure highlights the clinical and mechanistic convergence of conventional pharmacological therapies and selected nutraceuticals in ...
Laura Beatrice Mattioli   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy